Improving emergency department treatment for opioid use disorder
Measuring Improvement in the Quality of ED-initiated Treatment for OUD using Observation
['FUNDING_OTHER'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-10676110
This study is looking at how to make it easier for people with opioid use disorder to get help in emergency rooms by using a medication called buprenorphine, so they can receive better care and support right when they need it.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10676110 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the treatment of opioid use disorder (OUD) in emergency departments by using buprenorphine, a medication that can significantly reduce overdose deaths. The study aims to expand access to this treatment by implementing protocol-driven observation units that allow patients to receive care beyond the typical emergency visit duration. By addressing the challenges of providing quality care in emergency settings, the research seeks to improve patient outcomes and ensure that individuals struggling with OUD receive timely and effective treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing opioid use disorder and present to the emergency department.
Not a fit: Patients who are not experiencing opioid use disorder or those who do not seek treatment in emergency departments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to life-saving treatment for individuals with opioid use disorder in emergency settings.
How similar studies have performed: Previous research has shown that initiating buprenorphine treatment in emergency departments can be effective, indicating that this approach has potential for success.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MCCORMACK, RYAN P — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: MCCORMACK, RYAN P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.